← Open Payments lookup

CORAL ROSEBERRY: Open Payments

NPI 1255012860 · LA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,485 in 68 payments from 14 companies in 2025. Trend: 2023 $308 · 2024 $682 · 2025 $1,485

Food & beverage: $1,440Education: $45
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$306
Amgen Inc.19$293
Novo Nordisk Inc10$212
Lilly USA, LLC10$169
Boehringer Ingelheim Pharmaceuticals, Inc.7$139
Otsuka America Pharmaceutical, Inc.5$118
Lundbeck LLC2$45
SHIELD THERAPEUTICS INC2$42
Bayer Healthcare Pharmaceuticals Inc.2$37
ABBVIE INC.2$34

Products named: FARXIGA, REXULTI, EVENITY, JARDIANCE, OTEZLA, MOUNJARO, Wegovy, Ozempic.

Industry payments across CA — which companies pay providers there.